HeartSciences Inc. (HSCS) is a Medical - Devices company in the Healthcare sector, currently trading at $1.97. It has a SharesGrow Score of 38/100, indicating a weak investment profile with 2 out of 7 criteria passed.
Analyst consensus target is HSCS = $3 (+52.3% upside).
Valuation: HSCS trades at a trailing Price-to-Earnings (P/E) of -0.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.07.
Financials: revenue is $4,350, +40.1%/yr average growth. Net income is $9M (loss), growing at -3518.6%/yr. Net profit margin is -201499.5% (negative). Gross margin is -2884.7% (-2929.8 pp trend).
Balance sheet: total debt is $3M against $205,171 equity (Debt-to-Equity (D/E) ratio 14.55, leveraged). Current ratio is 0.59 (tight liquidity). Debt-to-assets is 70.7%. Total assets: $4M.
Analyst outlook: 3 / 3 analysts rate HSCS as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 0/100 (Fail), Future 100/100 (Pass), Income 10/100 (Fail).
